Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

Biohaven (NYSE:BHVN) stock gains on tumor-shrinking results for the company's cancer drug BHV-1510 with Regeneron's (REGN) ...

NEW YORK, May 26, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE: BHVN). Such investors are advised to ...

Biohaven Ltd. (NYSE:BHVN) Director John W. Childs has recently increased his stake in the company through the purchase of 28,000... ByInvesting.com • May 31, 2024 Biohaven shares hold steady ...

Investors in Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) need to pay close attention to the stock based on moves in ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

At close: May 22 at 11:00:27 a.m. EDT ...

Read Our Latest Analysis on NGG National Grid Stock Performance Shares of NGG stock opened at $74.78 on Friday. The company has a market cap of $73.17 billion, a price-to-earnings ratio of 14.38 ...

Read Our Latest Analysis on NVIDIA NVIDIA Stock Down 1.2% Shares of NASDAQ:NVDA opened at $131.29 on Friday. The company has a market capitalization of $3.21 trillion, a price-to-earnings ratio of ...